Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden
· Delayed Price · Currency is SEK 1.895
+0.010 (0.53%)
Mar 9, 2026, 5:29 PM CET
Sprint Bioscience AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 126.7 | 25.06 | 49.93 | 29.49 | 70.64 | Upgrade
|
| Cash & Short-Term Investments | 126.7 | 25.06 | 49.93 | 29.49 | 70.64 | Upgrade
|
| Cash Growth | 405.68% | -49.82% | 69.31% | -58.25% | 160.92% | Upgrade
|
| Accounts Receivable | - | - | 0.8 | 0.01 | 0.02 | Upgrade
|
| Other Receivables | 6.17 | 12.19 | 7.14 | 5.38 | 5.28 | Upgrade
|
| Receivables | 6.17 | 12.19 | 7.94 | 5.39 | 5.29 | Upgrade
|
| Total Current Assets | 132.87 | 37.24 | 57.87 | 34.88 | 75.94 | Upgrade
|
| Property, Plant & Equipment | 3.74 | 4.72 | 4.38 | 2.37 | 2.99 | Upgrade
|
| Long-Term Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.05 | 0.08 | 0.12 | 0.16 | Upgrade
|
| Total Assets | 136.66 | 42.06 | 62.38 | 37.42 | 79.14 | Upgrade
|
| Accounts Payable | 4.4 | 5.44 | 5.71 | 3.73 | 2.92 | Upgrade
|
| Accrued Expenses | - | 4.7 | 3.37 | 4.43 | 4.54 | Upgrade
|
| Current Unearned Revenue | - | 11.23 | 12.32 | - | - | Upgrade
|
| Other Current Liabilities | 13.08 | 11.42 | 13.21 | 1.07 | 1.22 | Upgrade
|
| Total Current Liabilities | 17.48 | 32.78 | 34.6 | 9.23 | 8.68 | Upgrade
|
| Total Liabilities | 17.48 | 32.78 | 34.6 | 9.23 | 8.68 | Upgrade
|
| Common Stock | 7.07 | 6.98 | 6.98 | 6.98 | 3.98 | Upgrade
|
| Additional Paid-In Capital | 291.75 | 273.67 | 273.9 | 273.87 | 258.97 | Upgrade
|
| Retained Earnings | -179.65 | -271.38 | -253.1 | -252.67 | -192.5 | Upgrade
|
| Shareholders' Equity | 119.18 | 9.27 | 27.77 | 28.19 | 70.45 | Upgrade
|
| Total Liabilities & Equity | 136.66 | 42.06 | 62.38 | 37.42 | 79.14 | Upgrade
|
| Net Cash (Debt) | 126.7 | 25.06 | 49.93 | 29.49 | 70.64 | Upgrade
|
| Net Cash Growth | 405.68% | -49.82% | 69.31% | -58.25% | 313.73% | Upgrade
|
| Net Cash Per Share | 1.35 | 0.36 | 0.72 | 0.70 | 2.45 | Upgrade
|
| Filing Date Shares Outstanding | 105.52 | 69.82 | 69.82 | 69.8 | 39.84 | Upgrade
|
| Total Common Shares Outstanding | 105.52 | 69.82 | 69.82 | 69.8 | 39.84 | Upgrade
|
| Working Capital | 115.39 | 4.46 | 23.27 | 25.65 | 67.25 | Upgrade
|
| Book Value Per Share | 1.13 | 0.13 | 0.40 | 0.40 | 1.77 | Upgrade
|
| Tangible Book Value | 119.18 | 9.27 | 27.77 | 28.19 | 70.45 | Upgrade
|
| Tangible Book Value Per Share | 1.13 | 0.13 | 0.40 | 0.40 | 1.77 | Upgrade
|
| Machinery | - | 10.96 | 9.66 | 7.21 | 7.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.